TuHURA Biosciences HURA
NASDAQ HURA
$2.00 -0.22 (-9.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

TuHURA Biosciences (HURA) Total Debt (2011 - 2025)

TuHURA Biosciences (HURA) posted quarterly Total Debt of $592000.0 for Q4 2025, little changed quarter-over-quarter from $592000.0 in Q3 2025.

TuHURA Biosciences (HURA) Total Debt (2011 - 2025) Analysis & Trends

TuHURA Biosciences' Total Debt history runs 14 years deep, the most recent figure standing at $592000.0 for Q4 2025.

  • In Q4 2025, Total Debt changed N/A year-over-year to $592000.0; the TTM figure through Dec 2025 stood at $592000.0 (changed N/A YoY), while the FY2025 annual figure was $592000.0, changed N/A from the prior year.
  • Total Debt for Q4 2025 stood at $592000.0, roughly flat from $592000.0 in the prior quarter.
  • The five-year high for Total Debt was $1.0 million in Q1 2021, with the low at $180000.0 in Q1 2023.
  • The 4-year median for Total Debt is $554500.0 (2021), against an average of $546916.7.
  • The sharpest annual moves came in 2021 and 2023: Total Debt soared 239.65% in 2021, then sank 60.7% in 2023.
  • TuHURA Biosciences' Total Debt stood at $543000.0 in 2021, then grew by 0.92% to $548000.0 in 2022, then sank by 45.62% to $298000.0 in 2023, then soared by 98.66% to $592000.0 in 2025.
  • Business Quant data shows HURA's Total Debt at $592000.0 in Q4 2025, $592000.0 in Q3 2025, and $298000.0 in Q2 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 591.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.07 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn -
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 770.36 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 546.77 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 9.34 Bn
10 TuHURA Biosciences 37.61 Mn 37.61 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 592,000.00
Sep 30, 2025 592,000.00
Jun 30, 2023 298,000.00
Mar 31, 2023 180,000.00
Dec 31, 2022 548,000.00
Sep 30, 2022 573,000.00
Jun 30, 2022 721,000.00
Mar 31, 2022 458,000.00
Dec 31, 2021 543,000.00
Sep 30, 2021 491,000.00
Jun 30, 2021 561,000.00
Mar 31, 2021 1.01 Mn
Dec 31, 2020 762,397.00
Sep 30, 2020 882,000.00
Jun 30, 2020 664,000.00
Mar 31, 2020 296,184.00
Dec 31, 2019 276,674.00
Sep 30, 2019 211,300.00
Jun 30, 2019 325,208.00
Mar 31, 2019 113,240.00